CRIR Workshop series #2: Discussion Activity : Transition-Teva-Intégration Emploi | September 28, 2022 - CRIR
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO | MarketScreener
DEF 14A
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | IL0006290147 | MarketScreener
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
DEF 14A
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
TEVA Earnings Date 2023 | Teva Pharmaceutical Industries Earnings Forecast
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement
DEF 14A
Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week (NYSE: TEVA) | Seeking Alpha
Teva jumps after Wall Street upgrades, analysts say stock 'too cheap to ignore'
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
Teva Pharmaceutical: What To Expect In 2023 With New CEO (NYSE:TEVA) | Seeking Alpha
Teva Reports Second Quarter 2021 Financial Results | Business Wire
DEF 14A
Teva Pharmaceutical Industries (NYSE:TEVA) Has No Shortage Of Debt | Nasdaq
